Data showed increased expression of FGF2, VEGFC, and BAIAP2 in tumoral tissue in six, five, and four FTC samples, respectively, whereas the same genes were overexpressed in five, six, and six NT tissues, respectively. The gene discussed is FGF2; the disease is thyroid cancer, nonmedullary, 2.